Sandoz

sandoz.it

Sandoz S.p.A.

Largo Umberto Boccioni 1
21040 Origgio
Italy

Phone

sandoz.it
Profile Products News

About Sandoz

Sandoz is a global generics leader. We save and improve lives by developing, producing and distributing high-quality, affordable pharmaceuticals. Thanks to our global network, Sandoz medicines are now available to 90% of people worldwide.

Read more about Sandoz

Advertisement

Digital membrane chromatography opens up new horizons in protein analysis
Digital membrane chromatography opens up new horizons in protein analysis
Advanced Bioprocess Data Management and Automation Platform
Advanced Bioprocess Data Management and Automation Platform
Holistic Multi-Column Chromatography Solution
Holistic Multi-Column Chromatography Solution

Product portfolio of Sandoz

Product portfolio

Show all

Advertisement

Continuous Low‑pH Virus Inactivation for Integrated Bioprocessing
Continuous Low‑pH Virus Inactivation for Integrated Bioprocessing
Industry-optimized ERP for the life sciences industry
Industry-optimized ERP for the life sciences industry
Screening and Purification for Large Biomolecules in Multi-Well Plate Design
Screening and Purification for Large Biomolecules in Multi-Well Plate Design

News about Sandoz

Sandoz

31-Jul-2025 | business & finance

Evotec and Sandoz agree on potential sale of Just – Evotec Biologics Toulouse site

Continuation of strategic collaboration

Read news
Sandoz

29-Jul-2020 | business & finance

Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe

Sandoz, the Novartis generics and biosimilars division, is pleased to announce plans for a joint investment, together with the Austrian federal government ...

Read news
Sandoz

14-Mar-2019 | people

Novartis announces change in Sandoz leadership

Novartis announced that Richard Francis will be stepping down as CEO of Sandoz, a Novartis division, and as a member of the Executive Committee of Novartis ...

Read news
Sandoz

20-Jan-2012 | research and development

Sandoz initiates two more Phase III biosimilar trials

Sandoz announced that it has initiated two milestone Phase III clinical trials - one for biosimilar filgrastim (Amgen's Neupogen®) in the US market, the ...

Read news
Sandoz

14-Jan-2011 | research and development

Sandoz announces phase II clinical trial for biosimilar version of leading monoclonal antibody rituximab

Sandoz announced that it has begun a phase II clinical trial in patients for biosimilar rituximab (Roche's Rituxan® / Mabthera®), a monoclonal antibody ...

Read news
Sandoz

27-Jul-2010 | research and development

Sandoz leads the way with first generic version of 'gold standard' anti-thrombotic Lovenox

Sandoz announced the introduction of enoxaparin sodium injection, the first generic version of Lovenox®, in the US. Product shipment began immediately ...

Read news
Sandoz

25-Sep-2009 | business & finance

Sandoz completes acquisition of EBEWE Pharma, improving global patient access to affordable injectable cancer medicines

Sandoz to focus on quick and seamless integration for customers and employees

Read news
Sandoz

08-Sep-2009 | politics & laws

Orion and Hospira,Inc. sue Sandoz companies in the U.S. to enforce their U.S. Patents covering the proprietary drug Precedex

Orion Corporation and Hospira, Inc. filed together a patent infringement lawsuit in the United States to enforce Orion's U.S. Patent No.4,910,214 and Orion ...

Read news
Sandoz

26-Jun-2009 | research and development

Sandoz receives approval for first-ever Japanese biosimilar

Sandoz receives approval for first-ever Japanese biosimilar, recombinant human growth hormone somatropin, further reinforcing global pioneer position in field

Read news
Sandoz

25-May-2009 | business & finance

Sandoz to acquire EBEWE Pharma specialty generics business, improving access for patients worldwide to injectable cancer drugs

Definitive agreement to acquire EBEWE Pharma's specialty injectables business for EUR 925 million (USD 1.2 billion) in an all-cash transaction

Read news
Sandoz

12-Oct-2006 | business & finance

LifeCycle Pharma Enters Three Distinct Strategic Collaboration Agreements With Global Pharmaceutical Companies

LifeCycle Pharma A/S announced that it has entered into three strategic collaboration agreements with Sandoz Inc. (an affiliate of Novartis AG), Merck ...

Read news
Sandoz

02-Feb-2006 | business & finance

GLSV co-finances Sandoz spin-off Nabriva GmbH

Global Life Science Ventures (GLSV) announced the launch of Nabriva GmbH, a specialist antibiotic research and development company that has existed until ...

Read news
Sandoz

16-Sep-2005 | politics & laws

Sandoz Files Lawsuit Seeking FDA Ruling on Omnitrope

Sandoz announced that it has filed a lawsuit against the US Food and Drug Administration, seeking a ruling on its pending new drug application for the ...

Read news
Sandoz

04-May-2005 | politics & laws

Sandoz, Inc. to Drop Challenge to PROVIGIL(R) Patent

Cephalon, Inc. reported that Sandoz, Inc. has notified Cephalon that it will no longer challenge Cephalon's U.S. particle-size modafinil patent. Instead, ...

Read news
Show more news about Sandoz

Advertisement

Advanced CHO Cell Line Development Technology for In-House Implementation
Advanced CHO Cell Line Development Technology for In-House Implementation
Chemically Defined Cell Culture Media for Viral Vector and Gene Therapy Applications
Chemically Defined Cell Culture Media for Viral Vector and Gene Therapy Applications
High-Performance Sterilizing-Grade Filtration for Solvents and Oily Formulations
High-Performance Sterilizing-Grade Filtration for Solvents and Oily Formulations

Here you will find Sandoz S.p.A.